Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis
L. Sese (Bobigny, France), J. Caliez (Bobigny, France), V. Cottin (Lyon, France), D. Israel-Biet (Paris, France), B. Crestani (Paris, France), S. Guillot-Dudoret (Rennes, France), J. Cadranel (Paris, France), B. Wallaert (Lille, France), A. Tazi (Paris, France), B. Maître (Créteil, France), G. Prévot (Toulouse, France), S. Marchan-Adam (Tours, France), S. Hirschi (Strasbourg, France), S. Dury (Reims, France), V. Giraud (Boulogne, France), A. Gondouin (Besançon, France), P. Bonniaud (Dijon, France), J. Traclet (Lyon, France), K. Juvin (Paris, France), R. Borie (Paris, France), T. Gille (Bobigny, France), Z. Carton (Bobigny, France), D. Valeyre (Bobigny, France), H. Nunes (Bobigny, France)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Sese (Bobigny, France), J. Caliez (Bobigny, France), V. Cottin (Lyon, France), D. Israel-Biet (Paris, France), B. Crestani (Paris, France), S. Guillot-Dudoret (Rennes, France), J. Cadranel (Paris, France), B. Wallaert (Lille, France), A. Tazi (Paris, France), B. Maître (Créteil, France), G. Prévot (Toulouse, France), S. Marchan-Adam (Tours, France), S. Hirschi (Strasbourg, France), S. Dury (Reims, France), V. Giraud (Boulogne, France), A. Gondouin (Besançon, France), P. Bonniaud (Dijon, France), J. Traclet (Lyon, France), K. Juvin (Paris, France), R. Borie (Paris, France), T. Gille (Bobigny, France), Z. Carton (Bobigny, France), D. Valeyre (Bobigny, France), H. Nunes (Bobigny, France). Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis. 777
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Predictors of influenza PCR positivity in acute exacerbations of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019 Year: 2019
The challenge of acute exacerbation of pulmonary fibrosis Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014
Acute exacerbation of idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 23: 792 Year: 2004
Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (2) 00036-2016; 10.1183/23120541.00036-2016 Year: 2017
Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010
Rate of flu vaccination in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 144s Year: 2004
Hospitalization for influenza among patients with chronic obstructive pulmonary disease Source: International Congress 2019 – Airway infection in COPD Year: 2019
Influenza A virus in exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 152s Year: 2001
Tumor-associated antigens in acute exacerbation of idiopathic pulmonary fibrosis: Associations with disease activity Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019 Year: 2020
Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease? Source: Annual Congress 2003 - COPD: risk factors and course of disease Year: 2003
Fatal acute exacerbation of idiopathic pulmonary fibrosis: report of 4 cases Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005
Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids Source: Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020 Year: 2020
Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019
Vulnerability of fatal infection under steroid treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009